USTEKINUMAB

USTEKINUMAB (13261Y)

ustekinumab 90 mg/mL injection, 1 mL syringe
13261Y
Body System:
Manner of administration:Injection
General Schedule
Authority Required

Restriction

Indication: Moderate to severe ulcerative colitis
Treatment phase: First continuing treatment

Restriction

Indication: Moderate to severe ulcerative colitis
Treatment phase: Subsequent continuing treatment

Restriction

Indication: Moderate to severe ulcerative colitis
Treatment phase: First continuing, Subsequent continuing treatment - balance of supply
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 1 # of repeats: 1 DPMQ: $986.28 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Stelara
Steqeyma
Wezlana